KZA Chart, page-75

one can expect the share price to appreciate as we move closer to the event, and...

this is fun no doubt - but one is reminded to be acquiring all one can for the main focus which may be announced at any time around a lic/partner deal for commercialisation.

not to mention the recent good news around RPDD and potential PRV worth up to 350 million USD and a saleable asset.

the point of holding this stock for years is not a few points here or there but the realisation of many collaborations, confirmed clinical results and an initial partnership deal - this ‘first’ deal will confirm the strategy the team has developed and in the process it will provide initial capital, milestone payments and annual revenues etc.

very exciting short mid and long term ATM